
United Kingdom · Biotechnology startup
Epoch Biodesign is a London-based synthetic biology company founded in 2019.
Funding reportedLast round: Undisclosed round
Epoch Biodesign is a London-based synthetic biology company founded in 2019.
The company focuses on using AI-designed enzymes to facilitate infinite, virgin-quality recycling of mixed plastics and blended textiles, starting with nylon 6,6. Their mission is to address climate challenges by breaking down complex waste into high-purity chemical building blocks, promoting a circular economy for difficult-to-recycle materials. The company employs a proprietary enzymatic biorecycling process that deconstructs plastic waste at the molecular level, producing recycled nylon 6,6 that matches the quality of virgin plastic. Epoch Biodesign serves B2B clients across various industries, including apparel, automotive, and packaging, providing sustainable materials and low-carbon chemical building blocks. With a team of around 32 scientists and engineers, the company is building a multi-tonne demo facility aimed at scaling production to 150 metric tonnes annually by 2026.
Funding, as reported
Epoch Biodesign filed 5 raises, $29M in all. Filings say how much was sold and to how many investors; they never name the investors.
What they build
Known for
nylon recyclingpolyester recyclingchemical depolymerizationlow-temperature processesbiotech for waste managementconsumer goods & retailmanufacturingsustainable materialsmaterials sciencewaste transformationclimate solutionsmolecular recyclingfossil carbon displacementwaste managementai and synthetic biologyplastic waste
Built with from their website
DockerAmazon CloudFrontWordPress.orgSalesforce CRM AnalyticsGoogle WorkspaceCloudFlareViewport MetaLinkedIn AdsEchoWebflow Hosting
AIGoogle MeetAct!CloudFlare CDNMistMobile FriendlyOpen GraphjQuery
Add your raise, your deck and your story, and put Epoch Biodesign in front of investors. Or tell us what we have wrong.